High serum HIF-1α levels are associated with intensive respiratory support in community acquired pneumonia

Autor: N Carrion Collado, A Comes Raga, F Sanz Herrero, G Marcaida Benito, E Fernández-Fabrellas

Publikováno v: 10.01 - Respiratory infections and bronchiectasis.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::76fd3ade6421c9f84f2b4dec54e95a15
https://doi.org/10.1183/13993003.congress-2022.2099

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Status of the implementation of pharmacogenetics in clinical practice in Spain: from regional to national initiatives.

Autor: Apellaniz-Ruiz M; Genomics Medicine Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain., Barrachina J; Neuropharmacology on Pain (NED) Group, Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain., Castro-Sanchez P; Department of Pathology and Surgery, Miguel Hernandez University, Alicante, Spain., Comes-Raga A; Clinical Analysis Department, Consorcio Hospital General Universitario de Valencia, Valencia, Spain., García-González X; Pharmacy Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Gil-Rodriguez A; Genomic Medicine Group, CIMUS, University of Santiago de Compostela, Santiago de Compostela, Spain.; Pharmacogenomics and Drug Discovery (GenDeM), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain., Lopez-Lopez E; Department of Biochemistry & Molecular Biology, Science and Technology Faculty, IIS Biobizkaia, UPV/EHU, Leioa, Spain., Maroñas O; Genomic Medicine Group, CIMUS, University of Santiago de Compostela, Santiago de Compostela, Spain.; Pharmacogenomics and Drug Discovery (GenDeM), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.; Foundation of Genomic Medicine, Galician Health Service (SERGAS), Santiago de Compostela, Spain.; Centre for Biomedical Research Network on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain., Morón R; Pharmacy Departament, Hospital Universitario Clínico San Cecilio, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (Ibs.GRANADA), Granada, Spain., Muriel J; Platform for Pharmacogenetics Applied to Research, Alicante Institute of Health and Biomedical Research (ISABIAL), Alicante, Spain., Olivera GG; Pharmacogenetics and Gene Therapy Unit, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.; Pharmacology Department, Universidad de Valencia, Burjassot, Spain., Riera P; Centre for Biomedical Research Network on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.; Pharmacy Department, Hospital de La Santa Creu I Sant Pau, Barcelona, Spain.; Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain., Saiz-Rodríguez M; Research Unit, Fundación Burgos por La Investigación de La Salud (FBIS), Hospital Universitario de Burgos, Burgos, Spain., Salvador-Martín S; Pharmacy Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Sans-Pola C; Department of Clinical Pharmacology, Vall D'Hebron Hospital Universitari, Vall D'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Tejera-Pérez H; Human Genotyping Unit, CeGen (Spanish National Genotyping Centre), Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Velasco-Ruiz A; Human Genotyping Unit, CeGen (Spanish National Genotyping Centre), Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Verde Z; Department of Biochemistry, Molecular Biology and Physiology, Universidad de Valladolid, Valladolid, Spain.; GIR -Pharmacogenetics, University of Valladolid, Valladolid, Spain., Wang D; Department of Clinical Pharmacology, Vall D'Hebron Hospital Universitari, Vall D'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Rodríguez-Vicente AE; Cancer Molecular and Cellular Diagnostics Unit, IBSAL, IBMCC-Cancer Research Center (USAL-CSIC), Salamanca, Spain.; Human Anatomy and Embryology Department, Faculty of Medicine, University of Salamanca, Salamanca, Spain., Nunez-Torres R; Human Genotyping Unit, CeGen (Spanish National Genotyping Centre), Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.

Publikováno v: Drug metabolism and personalized therapy [Drug Metab Pers Ther] 2024 Nov 11. Date of Electronic Publication: 2024 Nov 11.